Initial results of the first two-phase trials of the vaccine conducted in five trial sites in the U.K. showed it has an acceptable safety profile and homologous boosting increased antibody responses, the source said

Vaccine major Serum Institute of India's CEO Adar Poonawalla said on Monday the company will apply for COVID-19 vaccine trials within a week and will soon begin manufacturing the vaccine, developed by Oxford University, in large volumes

While there were concerns on whether the immunity would last in the case of COVID-19 vacccines under development, the results said T-cells, which directly target and kill infected cells, were induced by the vaccine

Remdesivir is made by Gilead Sciences Inc, which has committed to supplying 500,000 treatment courses of the drug to HHS for distribution to U.S in July, August and September

Developers of the vaccine, known as known as AZD1222, said earlier this month they were encouraged by the immune response they had seen in trials so far and were expecting to publish Phase 1 data by the end of July

Share price of Biocon rose 9.90% to  Rs 455 against previous close of Rs 414.30 on BSE

The approval was given after its clinical trials on COVID-19 patients in India was found satisfactory by the expert committee

Fauci said hopefully we'll be able to get some information, such as with this particular one representative vaccine that we started here in January

A Vigyan Prasar article claimed that none of the coronavirus vaccines under development around the world, including India, would be available for mass use before 2021; PIB omitted this warning while carrying this article on its portal

Coronavirus vaccine update: A coronavirus vaccine candidate tested by American firm Pfizer and German biotech major BioNTech SE has been found to generate antibodies in people, a study showed

While the general opinion of most experts and pharmaceutical companies is that a corona vaccine would be ready by mid-2021, researchers are still hoping for a 2020 breakthrough

Coronavirus vaccine update: Moderna has signed a deal with Catalent for large-scale manufacturing of its vaccine candidate. Catalent will provide vial filling and packaging capacity as well as additional workforce required for 24X7 manufacturing operations.

Coronavirus update: The Delhi government would prepare a strategy by Monday (June 22) and delineate all containment zones by June 26. By June 30, there would be a complete survey of all containment zones, and by July 6, there should be an extensive survey of the entire capital

On progress on treatment options for COVID-19, Cadila said it is working on a DNA vaccine to fight coronavirus, which is currently in the animal testing stage

Coronavirus vaccine update: Germany's CureVac AG has received approval from the government to conduct human trials. The coronavirus vaccine candidate would first be tested 168 health people according to the government

Coronavirus vaccine update: Scientists at the DSO have screened \"hundreds of thousands\" of B cells from the blood samples of the novel coronavirus patients who have recovered since March this year

The drug is being tested to see if it can reduce deaths from the COVID-19 illness and lessen its severity. Scientists at Lilly believe that baricitinib could help suppress a potentially lethal immune response to COVID-19

COVID-19 vaccine and drug latest news update: Gilead Sciences Inc had previously signed pacts with five other companies for manufacturing and sale of remdesivir; here are latest updates from across world on coronavirus vaccine developments

While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks

Lilly is also doing preclinical studies of a third antibody treatment for the illness caused by the new coronavirus that could enter human clinical trials in the coming weeks, Chief Scientific Officer Daniel Skovronsky said